• Login
    • Join
  • FOLLOW:
  • Subscribe Free
    • Magazine
    • eNewsletter
    Checkout
    • Magazine
    • News
    • Opinions
    • Top 30
    • Research
    • Supply Chain
    • Device Sectors
    • Directory
    • Events
    • Resources
    • Microsites
    • More
  • Magazine
  • News
  • Opinions
  • Top 30
  • Research
  • Supply Chain
  • Device Sectors
  • Directory
  • Events
  • Resources
  • Microsites
  • Current / Back Issues
    Features
    Editorial
    Digital Edition
    eNewsletter Archive
    Our Team
    Editorial Guidelines
    Reprints
    Subscribe Now
    Advertise Now
    Top Features
    Transporting Treatment: An Examination of Tubing Technologies

    Outward Appearance: Reviewing Surface Treatment Options

    Face to (Virtual) Face: Telemedicine Now and Post-Pandemic

    Voices for Medtech: AdvaMed and MDMA Leaders Share Thoughts

    Digitize Your QMS via an Enterprise Cloud Platform
    OEM News
    Supplier News
    Service / Press Releases
    Online Exclusives
    Press Releases
    People in the News
    Product & Service Releases
    Supplier News
    Medtech Makers
    Technical Features
    International News
    Videos
    Product & Service Releases
    Live From Shows
    Top News
    Iterative Scopes Announces IBD-Focused Scientific Advisory Board

    Vicarious Surgical, D8 Holdings Corp. Combine Operations in $1.1 Billion Deal

    FDA Grants De Novo Clearance to Medtronic’s GI Genius Model

    Acutus Medical Receives FDA Clearance of AcQCross

    Thermo Fisher Scientific to Acquire PPD for $17.4 Billion
    From the Editor
    Blogs
    Guest Opinions
    Top Opinions
    Transporting Treatment: An Examination of Tubing Technologies

    Outward Appearance: Reviewing Surface Treatment Options

    Face to (Virtual) Face: Telemedicine Now and Post-Pandemic

    Voices for Medtech: AdvaMed and MDMA Leaders Share Thoughts

    Digitize Your QMS via an Enterprise Cloud Platform
    Top 30 Medical Device Companies
    Market Data
    White Papers
    Top Research
    Home Is Where the Heart (Valve) Is

    CGM: Digital Health Meets a Very Large Opportunity

    Biomechanical Engineer, Heal Thyself

    Optimizing MIM in Medical Device Manufacturing

    PPE and Diagnostics: Sourcing Domestically and Speeding Time to Market
    3D/Additive Manufacturing
    Contract Manufacturing
    Electronics
    Machining & Laser Processing
    Materials
    Molding
    Packaging & Sterilization
    R&D & Design
    Software & IT
    Testing
    Tubing & Extrusion
    Cardiovascular
    Diagnostics
    Digital Health
    Neurological
    Patient Monitoring
    Surgical
    Orthopedics
    All Companies
    Categories
    Company Capabilities
    Add New Company
    Outsourcing Directory
    K-Tube Technologies

    FUTEK Advanced Sensor Technology Inc.

    Concise Engineering

    Trademark Plastics Inc.

    maxon
    MPO Summit
    Industry Events
    Webinars
    Live From Show Event
    Industry Associations
    Videos
    Career Central
    eBook
    Slideshows
    Top Resources
    Fiber Optics Introducing New Cleanliness Requirements for Medical Electronics

    EMS Providers Valued for Product Customization, Medical Certification Expertise

    Three Future Trends and Opportunities in Quality Assurance

    Adopting a Data-Driven Quality Model

    Digital Transformation for Quality and Manufacturing
    Companies
    News Releases
    Product Releases
    Press Releases
    Product Spec Sheets
    Service Releases
    Case Studies
    White Papers
    Brochures
    Videos
    Outsourcing Directory
    Concise Engineering

    Unicep

    Medicoil

    Qosina Corp.

    Medbio LLC
    • Magazine
      • Current/Back Issues
      • Features
      • Editorial
      • Columns
      • Digital Editions
      • Subscribe Now
      • Advertise Now
    • News
    • Directory
      • All Companies
      • ALL CATEGORIES
      • Industry Associations
      • Company Capabilities
      • Add Your Company
    • Supply Chain
      • 3D/Additive Manufacturing
      • Contract Manufacturing
      • Electronics
      • Machining & Laser Processing
      • Materials
      • Molding
      • Packaging & Sterilization
      • R&D & Design
      • Software & IT
      • Testing
      • Tubing & Extrusion
    • Device Sectors
      • Cardiovascular
      • Diagnostics
      • Digital Health
      • Neurological
      • Patient Monitoring
      • Surgical
      • Orthopedics
    • Top 30 Company Report
    • Expert Insights
    • Slideshows
    • Videos
    • Podcasts
    • Resources
    • eBook
    • Infographics
    • Whitepapers
    • Research
      • White Papers
      • Case Studies
      • Product Spec Sheets
      • Market Data
    • MPO Summit
    • Events
      • Industry Events
      • Live From Show Events
      • Webinars
    • Microsite
      • Companies
      • Product Releases
      • Product Spec Sheets
      • Services
      • White Papers / Tech Papers
      • Press Releases
      • Videos
      • Literature / Brochures
      • Case Studies
    • About Us
      • About Us
      • Contact Us
      • Advertise with Us
      • eNewsletter Archive
      • Privacy Policy
      • Terms of Use
    Online Exclusives

    Problem-Solving is Key to Effective R&D

    A better understanding of a medical issue enables companies to drive innovation efforts towards holistic solutions.

    Problem-Solving is Key to Effective R&D
    A formula for successful innovation. Image courtesy of Meddux Development Corporation.
    Michael Barbella, Managing Editor05.05.20
    It will be different next time. Much different, hopefully.
     
    Future pandemics are unlikely to resemble the disjointed patchwork of COVID-19 mitigation efforts implemented worldwide by lawmakers and health officials. Instead, they possibly will involve more coordinated responses and widespread testing, as well as technological innovations inspired by design thinking.
     
    Such thinking could result in redesigned public spaces that double as treatment areas during an outbreak and airports with more security screening lanes. Hospitals are likely to rethink conventional schematics too, potentially employing such pandemic-busting features as negative pressure zones, special patient evaluation areas, telehealth centers, and flexible-use rooms (i.e., those easily modified between acute care and ICU).
     
    With the COVID-19 threat unlikely to abate in the fore- seeable future, design thinking could potentially become a powerful tool in helping to better manage and control forthcoming pandemics. The approach is already being used to improve healthcare equity and spawn creative solutions to medicine’s most pressing dilemmas.
     
    MPO’s January/February feature, “Inventive Interaction,” explores the various forces at play in medtech R&D. David Schechter, president of Meddux Development Corporation, was among the various experts interviewed for the story. His full input is provided in the following Q&A.
     
    Michael Barbella: Where are companies spending their research dollars now—on incremental improvements to existing devices, or game-changing innovation?
    David Schechter:Large companies are much more likely to focus internal R&D on derivative products and incremental improvements in established markets. Large companies have worked hard to gain significant market share and to develop an installed base of loyal customers. Game-changing innovation is not only risky but it can be costly to the established business and to the existing customer base. Startup companies are conversely tasked with creating new markets and demonstrating that providers and payers are willing to adopt and pay for game-changing and innovative new therapies and treatments. Once early market acceptance and clinical data are established, large companies have the resources and channel control to come in and fully develop the market.
    If we look at large-scale trends in medical devices, there is a shift towards smart devices and the need to aggregate and analyze significant amounts of data more efficiently. With this access to data there is a paradigm shift where individual patients will be required to take more ownership of their own care. This will change how medical devices are designed, developed, and delivered to the patient. This dynamic is certainly apparent in diagnostics and consumer health, but there are also significant trends towards smart devices in areas such as interventional devices, minimally invasive surgical devices, advanced endoscopy, and active implants.
     
    Barbella: How is value-based healthcare shaping the kinds of medical devices/technology being developed?
    Schechter
    : Too often we are led to believe product innovation is synonymous with technological advancement. Technologies are enablers of innovation, but they are not one and the same. Essentially, technology provides the building blocks that we can assemble to solve real-world problems. From the perspective of value-based healthcare, new product innovations must apply technologies in a way that translates into increases in productivity, increased efficiency, avoidance of costly complications, or the ability to economically treat patients that we couldn’t otherwise treat. Too often we are enamored with new technologies and then are on a quest to find where they could be applied and what the expressed the benefits might be. With value-based healthcare, we must analyze the delivery of patient care as a business process and find solutions to optimize the inefficiencies in the process. We need to move away from the focus on the “device” and think more holistically across the entire patient-care spectrum and start to think procedurally. Economic drivers behind value-based medicine, however, cannot be the only factors to consider—we must also continue to strive to make innovative gains towards safer, more usable, more reliable, more consistent, and more clinically efficacious devices and treatments. Innovation is an imperative, and in most cases it is discontinuous. In most cases, economic value is only realized once technologies are matured and the product is delivered at scale.
     
    Barbella: Please discuss the importance of university/academic partnerships in developing cutting-edge medical devices.
    Schechter: University-based research exists to expand our fundamental understanding and knowledge in emerging areas of science and technology. Historically, most significant technological breakthroughs have been derived from academic or government- sponsored research. However, in most cases the academic environment is not capable of translating technology from research to viable commercial applications. This is most likely because innovation must start from understanding the critical need and problem and then identify appropriate technological solutions, and not vice versa. It is very difficult to start with a technology and then search for a problem to solve. University and academic partnerships are best served when potential applications of state-of-the-art technologies have been identified, but further development and refinement is necessary to translate the technology to a commercially viable solution for the specific application.
     
    Barbella: Are startups better suited than their mid-size or large OEM cohorts to develop medical technology that addresses value-based healthcare solutions? If so, how? (Or, if not, why not?)
    Schechter: The answer is twofold. Large OEMs are more likely to have the ability to go after and own an entire procedure and, more broadly, the entire patient experience from start to finish, giving them the control required to optimize total value delivered to patients, providers, and payers. At the same time, large OEMs are slow to enact change and react to changes in market dynamics. Startups are more likely to have the ability to react quickly and can bring disruptive innovations into play that change how patient care is delivered. It is critical however to focus broadly on market development rather than singularly on product development. It is essential to start with a clear understanding on how new innovations can bring value in terms of productivity, efficiency, cost-avoidance, or access to patients they we could not otherwise easily treat.
     
    Barbella: Can a company effective tackle a healthcare need/problem and devise a solution based on its own internal R&D? Please explain.
    Schechter: It depends. Internal R&D teams tend to be built around expertise in specific technology areas. In many cases, and specifically if you are thinking along the lines of delivering a value-based solution across an entire procedure or patient experience, a broad approach to enabling technologies is required. In short, the expertise of existing internal R&D teams may be too narrow. Many companies may then be challenged with building an entirely new area of expertise with their R&D organization or accessing critical technology knowledge gaps through strategic partnerships and development partners.
     
     
    Barbella: How can companies “innovate the process of innovation” to achieve more transformational products through R&D?
    Schechter: We have all heard a lot about “Design Thinking” methodologies that require us to better understand the user experience and empathize with the user. No doubt this is essential, but there are several common pitfalls that we tend to fall into when we try to innovate. We tend to over-focus on technological solutions and features, and it is typical to fundamentally underestimate the problem we are trying to solve. Technologies and features are shiny objects that may, in fact, add only limited benefits to select users—but they also significantly increase complexity and costs. We could almost always spend more time and energy up front to better understand the problem we are trying to solve. This allows us to drive innovation efforts towards holistic solutions that can broadly solve user needs. We should do this with an approach that helps us better understand the entire procedure and workflow, and also one that has less emphasis on a single-product solution. Our goal is to create a solution that is desirable (users), feasible (engineering), and viable (business). Which means that we need to assess not only user needs, but balance technical risk and whether the value delivered to customers is justified by the business case.
     
     
    Barbella: How will AI, big data, and digital health affect the R&D process going forward?
    Schechter: We are seeing an exponential growth in the amount of data and analytics we have about our individual health. Patients will have access to better and more specific data and in some cases may be more empowered to monitor and maintain their own health or disease state. This is a paradigm shift where data analytics, decision algorithms, and devices must be designed with a new set of users in mind (end-patients and not trained clinicians). It is also important to recognize that the vast majority of our current healthcare epidemics (obesity, diabetes, heart disease, cancer) result from behavioral and lifestyle choices. Will access to data through AI, big data, and digital health be effective enough for patients to enact real change?
     
     
    Barbella: What is driving the need to outsource medtech R&D? Does the R&D process even need to be outsourced?
    Schechter: Outsourcing specific aspects of R&D is a critical strategy that can shorten product development lead times and improve capital efficiency. The primary reason to outsource aspects of your product development program is to access experience and expertise that is not readily available within your internal teams. It is too costly to reinvent the wheel and learn every step of the way. You should engage a partner that is able to bring significant experience and technical expertise relating to your specific program. Outsourcing aspects of your product development program can also result in improved capital efficiency. This allows you to turn fixed costs into variable costs, effectively allowing you to throttle resources as necessary depending on the stage of development and prioritization of product development portfolios within a company.
     
     
    Related Searches
    • R&D & Design
    Related Knowledge Center
    • R&D & Design

    Related Online Exclusives

    • R&D & Design
      How Design Controls Can Prevent Medical Device Recalls

      How Design Controls Can Prevent Medical Device Recalls

      Incorporating risk management early in development will help eliminate problems before they impact the product’s manufacturing lifecycle.
      Ramya Sriram, Digital Content Manager, Kolabtree 11.16.20

    • R&D & Design | Software & IT
      COVID-19 Marks a Need for Virtual Development Tech

      COVID-19 Marks a Need for Virtual Development Tech

      Medical device developers can gain benefits from the use of MR/AR, but challenges need to be addressed first.
      Dijam Panigrahi, Co-Founder and COO, Grid Raster Inc. 08.10.20

    • R&D & Design
      From the Experts: Best Practices to Ensure Device Success

      From the Experts: Best Practices to Ensure Device Success

      Experts break down the issues device makers are faced with.
      Jon Speer, Founder and VP of QA/RA at Greenlight Guru 07.27.20


    • R&D & Design
      Catheter Ablation Technology and the Circular Economy

      Catheter Ablation Technology and the Circular Economy

      How device manufacturers can benefit from this different methodology.
      Lars Thording, VP of Marketing & Public Affairs at Innovative Health LLC 07.09.20

    • R&D & Design
      Human Factors Activities at a Safe Distance

      Human Factors Activities at a Safe Distance

      How to keep medical device development on track during the COVID-19 pandemic.
      Timothy Visich and Kate MacNamee, Program Managers, Senior Human Factors Engineers at Farm, a Flex company 06.03.20

    • Digital Health | R&D & Design
      The Four Steps of Design Acceleration

      The Four Steps of Design Acceleration

      How to meet the needs of manufacturers, clinicians, healthcare workers, and patients in the ‘new normal.’
      Ken Olewiler, Founder and Managing Director of Punchcut 06.01.20


    • R&D & Design
      6 Questions To Ask When Developing a Wearable Medical Device

      6 Questions To Ask When Developing a Wearable Medical Device

      How to design around skin—the unique substrate your device will adhere to.
      Del R. Lawson, Ph.D., and Kris Godbey 05.28.20

    • R&D & Design
      Medtech R&D Process Aided by Big Data, AI

      Medtech R&D Process Aided by Big Data, AI

      Digital health allows researchers and engineers to incorporate data sets of user behaviors into their prototypes during the early phases of R&D.
      Michael Barbella, Managing Editor 05.13.20

    • R&D & Design
      COVID-19 Pandemic Brings Fast-Track Innovation to Forefront

      COVID-19 Pandemic Brings Fast-Track Innovation to Forefront

      A look at the ways in which The Innovation Institute and its community is introducing new technologies for the effort against the virus.
      Joe Randolph, President and CEO, The Innovation Institute 04.28.20


    • R&D & Design
      Medtech R&D Must Address Outcomes in Value-Based Care

      Medtech R&D Must Address Outcomes in Value-Based Care

      Clinical requirements are no longer the only cornerstone of medical device development.
      Michael Barbella, Managing Editor 04.24.20

    • R&D & Design
      Smaller Businesses Beget Better Innovation

      Smaller Businesses Beget Better Innovation

      Despite their global sales reach, large firms tend to focus on nurturing existing product lineups.
      Michael Barbella, Managing Editor 04.16.20

    • R&D & Design
      Lessons Learned in Developing an Award-Winning Healthcare Product

      Lessons Learned in Developing an Award-Winning Healthcare Product

      Finding the right design partner helped ensure the proper pieces fell into place.
      Brandy George, Content Strategist, Zen Media 03.03.20


    • R&D & Design | Software & IT
      How Gamification Is a Boon to Medtech and Edtech

      How Gamification Is a Boon to Medtech and Edtech

      The positive attributes of gamification and why it works.
      Kelly Choo, Chief Marketing Officer and Co-Founder of Neeuro Pte Ltd. 01.16.20

    • R&D & Design
      Localizing Medical Devices

      Localizing Medical Devices

      Why translating medical devices is not enough.
      Ofer Tirosh, CEO of Tomedes 12.11.19

    • R&D & Design
      How to Minimize Color Variations in Your Medical Device

      How to Minimize Color Variations in Your Medical Device

      The key to making a medical device look great is to minimize obvious defects that catch the eye.
      Dana Trousil, Medical NPI Team Lead, StarFish Medical 12.03.19


    Trending
    • 7 Considerations For Designing Medical Device Mechanisms
    • Portable, Home-Use Device Quickly Measures Inflammation Levels
    • Thermo Fisher Scientific To Acquire PPD For $17.4 Billion
    • Katena Acquires Ophthalmic Surgical Instrument Maker ASICO
    • Harnessing Critical Health Data With Wearable Technology
    Breaking News
    • Iterative Scopes Announces IBD-Focused Scientific Advisory Board
    • Vicarious Surgical, D8 Holdings Corp. Combine Operations in $1.1 Billion Deal
    • FDA Grants De Novo Clearance to Medtronic’s GI Genius Model
    • Acutus Medical Receives FDA Clearance of AcQCross
    • Thermo Fisher Scientific to Acquire PPD for $17.4 Billion
    View Breaking News >
    CURRENT ISSUE

    April 2021

    • Transporting Treatment: An Examination of Tubing Technologies
    • Face to (Virtual) Face: Telemedicine Now and Post-Pandemic
    • Outward Appearance: Reviewing Surface Treatment Options
    • View More >

    Cookies help us to provide you with an excellent service. By using our website, you declare yourself in agreement with our use of cookies.
    You can obtain detailed information about the use of cookies on our website by clicking on "More information”.

    • About Us
    • Privacy Policy
    • Terms And Conditions
    • Contact Us

    follow us

    Subscribe
    Nutraceuticals World

    Latest Breaking News From Nutraceuticals World

    AstaReal Astaxanthin Ingredient Receives U.S. Patent Approval
    Study on Kemin’s DailyZz Botanical Blend Uncovers Sleep Quality, Next-Day Performance Benefits
    FDA’s Dr. Cara Welch Opening Speaker at the 9th AHPA Botanical Congress
    Coatings World

    Latest Breaking News From Coatings World

    Jebsen & Jessen, Innospec Sign Distribution Agreement
    IGL Coatings Announces Partnership in Finland
    Axalta Schedules 1Q 2021 Earnings Conference Call
    Medical Product Outsourcing

    Latest Breaking News From Medical Product Outsourcing

    Iterative Scopes Announces IBD-Focused Scientific Advisory Board
    Vicarious Surgical, D8 Holdings Corp. Combine Operations in $1.1 Billion Deal
    FDA Grants De Novo Clearance to Medtronic’s GI Genius Model
    Contract Pharma

    Latest Breaking News From Contract Pharma

    Bristol Myers Squibb Expands at Cambridge Crossing
    Amgen Completes Five Prime Acquisition
    Sartorius Expands in the UK
    Beauty Packaging

    Latest Breaking News From Beauty Packaging

    Former L’Oréal Exec Joins Glossier
    Lancôme Reveals New Global Sustainability Program
    First-Ever Skincare Line Focuses on Iron To Prevent Aging
    Happi

    Latest Breaking News From Happi

    Fragrance Creators Association Celebrates P&G Executive
    What You're Reading on Happi.com
    Former L’Oréal Exec Joins Glossier
    Ink World

    Latest Breaking News From Ink World

    Kumon North America Adds Speedmaster XL 106 from Heidelberg
    SE-DA Invests in Kornit Presto S
    Acrylic Resins Market Worth $21.9 Billion by 2025: MarketsandMarkets
    Label & Narrow Web

    Latest Breaking News From Label & Narrow Web

    TLMI reveals Eugene Singer Award winners at Virtual Spring Summit
    Monadnock Paper Mills joins SGP
    ACTEGA helps converter reach sustainability goals
    Nonwovens Industry

    Latest Breaking News From Nonwovens Industry

    Albaad to Add Natural-Based Line in Israel
    First Quality to Discontinue Tampon Operations
    Jessup Installs New Era Coating and Laminating Line
    Orthopedic Design & Technology

    Latest Breaking News From Orthopedic Design & Technology

    BioMagnetic Sciences Names President and CEO
    Mainstay Medical Launches ReActiv8 in Australia
    Biogennix Rolls Out Agilon Strip Bone Graft
    Printed Electronics Now

    Latest Breaking News From Printed Electronics Now

    Virtual ASMC 2021 Spotlights Advanced Semiconductor Manufacturing Excellence
    LG Display Cuts Down CO2-eq Emissions by 3 Million Tons in 2020
    European Commission's Innovation Radar Acknowledges 3 ARMOR Innovations

    Copyright © 2021 Rodman Media. All rights reserved. Use of this constitutes acceptance of our privacy policy The material on this site may not be reproduced, distributed, transmitted, or otherwise used, except with the prior written permission of Rodman Media.

    AD BLOCKER DETECTED

    Our website is made possible by displaying online advertisements to our visitors.
    Please consider supporting us by disabling your ad blocker.


    FREE SUBSCRIPTION Already a subscriber? Login